11-12 October, 2016 - USP, Rockille, Maryland

3rd Statistical and Data Management Approaches
for Biotechnology Drug Development

USP Headquarters, Rockville, Maryland
October 11-12, 2016

Co-organized by IABS and FDA

The 3rd annual stats & data management meeting will bring together regulators, and scientists, or those interested in statistics from academia and industry, who have a background in statistics, to continue exploring how best to resolving existing challenges in ensuring the quality of biotechnology medicinal products and to bring high quality medicines to patients. Guidance on how to use statistics for a variety of activities required during biotechnology product development such as method development, improvement and replacement, product comparability, biosimilarity exercises and stability program development will be provided by the speakers and panel members. In addition, the complexity of the types of data and the volume being analysed is ever increasing and how best to manage such data will be discussed. The meeting will bring the right experts together to discuss the issues and through roundtables attempt to reach conclusions that will be valuable globally to public health.

folder Slides are available here

International Alliance for Biological Standardization


Twitter Feed

#IABS#AUTOGENOUSVACCINES and their role in #ANIMALHEALTHSTRATEGY: differences to minor markets/minor use(#MUMS) emergency-regular licensing
Whole #sporozoitemalariavaccine proposed pivotal role for HCT discussed at #IABS #HUMANCHALLENGETRIALS. Register at https://t.co/f5eiaCgM2T
Follow IABS_global on Twitter

Contact Info

IABS, Rue de la Vallée, 3
CH-1204 Geneva

Switzerland
+ 41 22 301 10 36
+ 41 22 301 10 37
This email address is being protected from spambots. You need JavaScript enabled to view it.